These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 9236419)
21. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. Davì G; Catalano I; Averna M; Notarbartolo A; Strano A; Ciabattoni G; Patrono C N Engl J Med; 1990 Jun; 322(25):1769-74. PubMed ID: 2345567 [TBL] [Abstract][Full Text] [Related]
22. 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. Catella F; Healy D; Lawson JA; FitzGerald GA Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5861-5. PubMed ID: 3461463 [TBL] [Abstract][Full Text] [Related]
23. Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage. van Kooten F; Ciabattoni G; Koudstaal PJ; Dippel DW; Patrono C Stroke; 1999 Mar; 30(3):546-9. PubMed ID: 10066850 [TBL] [Abstract][Full Text] [Related]
24. Thromboxane biosynthesis and future events in diabetes: the ASCEND trial. Petrucci G; Buck GA; Rocca B; Parish S; Baigent C; Hatem D; Mafham M; Habib A; Bowman L; Armitage J; Patrono C Eur Heart J; 2024 Apr; 45(15):1355-1367. PubMed ID: 38385506 [TBL] [Abstract][Full Text] [Related]
25. Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype. Vazzana N; Ganci A; Cefalù AB; Lattanzio S; Noto D; Santoro N; Saggini R; Puccetti L; Averna M; Davì G J Am Heart Assoc; 2013 Apr; 2(2):e000063. PubMed ID: 23557750 [TBL] [Abstract][Full Text] [Related]
26. In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance. Santilli F; Zaccardi F; Liani R; Petrucci G; Simeone P; Pitocco D; Tripaldi R; Rizzi A; Formoso G; Pontecorvi A; Angelucci E; Pagliaccia F; Golato M; De Leva F; Vitacolonna E; Rocca B; Consoli A; Patrono C Diabetes Metab Res Rev; 2020 Feb; 36(2):e3232. PubMed ID: 31671234 [TBL] [Abstract][Full Text] [Related]
28. Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease. Adatia I; Barrow SE; Stratton PD; Miall-Allen VM; Ritter JM; Haworth SG Circulation; 1993 Nov; 88(5 Pt 1):2117-22. PubMed ID: 8222105 [TBL] [Abstract][Full Text] [Related]
29. Increased renal TXA2 synthesis in diabetes mellitus: simultaneous determination of urinary TXB2 and 2,3-dinor-TXB2. Katayama S; Inaba M; Maruno Y; Omoto A; Kawazu S; Ishii J; Sawada M Prostaglandins Leukot Essent Fatty Acids; 1990 Jan; 39(1):47-51. PubMed ID: 2339136 [TBL] [Abstract][Full Text] [Related]
30. Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. Lupinetti MD; Sheller JR; Catella F; Fitzgerald GA Am Rev Respir Dis; 1989 Oct; 140(4):932-5. PubMed ID: 2508524 [TBL] [Abstract][Full Text] [Related]
31. Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease. Vazzana N; Santilli F; Lattanzio S; Liani M; Giacci L; Del Rosso G; Salvati F; Boccatonda A; Ferroni P; Davì G Eur J Intern Med; 2016 Sep; 33():74-80. PubMed ID: 27389698 [TBL] [Abstract][Full Text] [Related]
32. Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment. Santilli F; Paloscia L; Liani R; Di Nicola M; Di Marco M; Lattanzio S; La Barba S; Pascale S; Mascellanti M; Davì G J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037196 [TBL] [Abstract][Full Text] [Related]
33. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Minuz P; Patrignani P; Gaino S; Degan M; Menapace L; Tommasoli R; Seta F; Capone ML; Tacconelli S; Palatresi S; Bencini C; Del Vecchio C; Mansueto G; Arosio E; Santonastaso CL; Lechi A; Morganti A; Patrono C Circulation; 2002 Nov; 106(22):2800-5. PubMed ID: 12451006 [TBL] [Abstract][Full Text] [Related]
34. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Cipollone F; Patrignani P; Greco A; Panara MR; Padovano R; Cuccurullo F; Patrono C; Rebuzzi AG; Liuzzo G; Quaranta G; Maseri A Circulation; 1997 Aug; 96(4):1109-16. PubMed ID: 9286937 [TBL] [Abstract][Full Text] [Related]
35. Insulin resistance as a determinant of platelet activation in obese women. Basili S; Pacini G; Guagnano MT; Manigrasso MR; Santilli F; Pettinella C; Ciabattoni G; Patrono C; Davì G J Am Coll Cardiol; 2006 Dec; 48(12):2531-8. PubMed ID: 17174194 [TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. Davì G; Neri M; Falco A; Festi D; Taraborelli T; Ciabattoni G; Basili S; Cuccurullo F; Patrono C Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):246-51. PubMed ID: 15472127 [TBL] [Abstract][Full Text] [Related]
37. Chronic dietary supplementation with L-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo. Bode-Böger SM; Böger RH; Kienke S; Böhme M; Phivthong-ngam L; Tsikas D; Frölich JC Cardiovasc Res; 1998 Mar; 37(3):756-64. PubMed ID: 9659460 [TBL] [Abstract][Full Text] [Related]
38. Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo". Landolfi R; De Candia E; Rocca B; Ciabattoni G; Antinori A; Masetti R; Patrono C Thromb Haemost; 1994 Dec; 72(6):942-6. PubMed ID: 7740468 [TBL] [Abstract][Full Text] [Related]
39. Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests. Gresele P; Catalano M; Giammarresi C; Volpato R; Termini R; Ciabattoni G; Nenci GG; Davì G Thromb Haemost; 1997 Dec; 78(6):1434-7. PubMed ID: 9423790 [TBL] [Abstract][Full Text] [Related]